Parvovirus Vp1 unique region polypeptides and compositions thereof
US10030052B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2012 |
| Grant date | Jul 24, 2018 |
| Priority date | — |
| Expiry date | Jul 25, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to mutant parvovirus VP1 unique region polypeptides, compositions comprising such polypeptides, methods of making such compositions, as well as methods for identifying the likely presence of parvovirus-neutralizing antibodies, and methods for assessing the functional immunogenicity of parvovirus vaccines and measuring a correlate of efficacy to assess a treatment for parvovirus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.